Immune Response News and Research

RSS

Georgia State researcher wins $3.26 million federal grant to develop universal flu vaccine

Influenza remains a major public health risk, and Dr. Baozhong Wang, associate professor in Georgia State University's Institute for Biomedical Sciences, has received a five-year, $3.26 million federal grant to combat this threat by developing a universal vaccine that offers more protection against influenza than seasonal vaccines.

2 Jul 2019

Standard tests may not detect low-level case of TB in some people

An international collaboration of infectious disease experts has identified a large group of people who appear to have naturally mounted an immune response to TB, a bacterial infection that is the leading cause of infectious disease death worldwide.

1 Jul 2019

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019

Pharmaceutical products made of solid gold

Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.

28 Jun 2019

Scientists discover pathway that prevents buildup of Alzheimer's protein

St. Jude Children's Research Hospital scientists have discovered a pathway that functions like a car wash to prevent the buildup of a toxic protein associated with Alzheimer's disease. The report appeared online today in the journal Cell.

28 Jun 2019

Researchers use genetically manipulated virus to combat prostate cancer

Researchers at the São Paulo State Cancer Institute in Brazil have succeeded in using a genetically manipulated virus to destroy tumor cells upon injection into mice with prostate cancer.

27 Jun 2019

Researchers study link between childhood viral infections and cerebral autoimmune disease

Although the exact causes of multiple sclerosis still remain unknown, it is assumed that the disease is triggered by a combination of genetic and environmental risk factors.

26 Jun 2019

New route to quickly transport subcutaneously administered antibodies into lymph nodes

Researchers from the University of Turku have discovered a new route that transports subcutaneously administered antibodies into lymph nodes in just a few seconds.

26 Jun 2019

Higher levels of doublets in flow cytometry indicate tuberculosis or dengue fever

Sorting through individual immune cells is a handy way to see how the body responds to disease. For years, researchers around the world have used a technique called flow cytometry to separate different types of immune cells, such as T cells, B cells and monocytes.

26 Jun 2019

Researchers reveal fundamental role of protein associated with Alzheimer's

Researchers from the University of Seville, the Seville Biomedicine Institute and Lund University have been able to describe how the body responds to a component present in the brain in Alzheimer's patients.

25 Jun 2019

Researchers explore new immune checkpoint for head and neck cancer

A checkpoint may delay travelers but it can help give cancer free rein by suppressing the natural immune response that should destroy it, researchers say.

25 Jun 2019

Natural antibiotic made by Tübingen researchers interacts with human defense mechanisms

The natural antibiotic Lugdunin, discovered three years ago by Tübingen researchers, attacks pathogenic bacteria in several different ways simultaneously.

24 Jun 2019

Non-classical monocytes directly involved in regulation of immune response

Non-classical monocytes were long thought to play a purely surveillance role in the immune system. With the aid of a novel marker, Ludwig-Maximilians-Universitaet in Munich researchers have now shown that they are directly involved in the regulation of immune response

24 Jun 2019

Researchers discover new immune cells that are at the frontline of HIV infection

Researchers at The Westmead Institute for Medical Research have discovered brand new immune cells that are at the frontline of HIV infection. Known as CD11c+ dendritic cells, these new cells are more susceptible to HIV infection and can then transmit the virus to other cells.

24 Jun 2019

Study: Micronutrient deficiencies are common in adults at the time of celiac disease diagnosis

Micronutrient deficiencies, including vitamins B12 and D, as well as folate, iron, zinc and copper, are common in adults at the time of diagnosis with celiac disease.

24 Jun 2019

Study reveals genetic signature of failed immune response to cancer

Our immune system is programmed to destroy cancer cells. Sometimes it has trouble slowing disease progression because it doesn't act quickly or strongly enough.

21 Jun 2019

Researchers develop model of intestinal infection that could advance vaccine development

The intestinal parasite Cryptosporidium, which causes a diarrheal disease, is very good at infecting humans. It's the leading cause of waterborne disease from recreational waters in the United States.

21 Jun 2019

Newly discovered antibody broadly inhibits multiple strains of pandemic norovirus

Researchers at the University of North Carolina at Chapel Hill Gillings School of Global Public Health and their colleagues at the University of Texas at Austin and the National Institutes of Health Vaccine Research Center have discovered an antibody that broadly inhibits multiple strains of pandemic norovirus, a major step forward in the development of an effective vaccine for the dreaded stomach virus.

19 Jun 2019

Researchers find way to reinvigorate exhausted immune cells and stop cancer

The human immune system relies on a delicate balance of finely tuned cell types that keep germs and cancerous cells in check.

18 Jun 2019

Virus employs powerful strategy to inhibit natural killer cell function

The virus responsible for chickenpox and shingles employs a powerful strategy of immune evasion, inhibiting the ability of natural killer cells to destroy infected cells and produce molecules that help control viral infection, according to a study published June 13 in the open-access journal PLOS Pathogens by Allison Abendroth of the Discipline of Infectious Diseases and Immunology in the Charles Perkins Centre at the University of Sydney, and colleagues.

From PLOS ONE 14 Jun 2019

Immune Response News and Research

Georgia State researcher wins $3.26 million federal grant to develop universal flu vaccine

Standard tests may not detect low-level case of TB in some people

Comprehensive gene activity database could significantly reduce animal use

Pharmaceutical products made of solid gold

Scientists discover pathway that prevents buildup of Alzheimer's protein

Researchers use genetically manipulated virus to combat prostate cancer

Researchers study link between childhood viral infections and cerebral autoimmune disease

New route to quickly transport subcutaneously administered antibodies into lymph nodes

Higher levels of doublets in flow cytometry indicate tuberculosis or dengue fever

Researchers reveal fundamental role of protein associated with Alzheimer's

Researchers explore new immune checkpoint for head and neck cancer

Natural antibiotic made by Tübingen researchers interacts with human defense mechanisms

Non-classical monocytes directly involved in regulation of immune response

Researchers discover new immune cells that are at the frontline of HIV infection

Study: Micronutrient deficiencies are common in adults at the time of celiac disease diagnosis

Study reveals genetic signature of failed immune response to cancer

Researchers develop model of intestinal infection that could advance vaccine development

Newly discovered antibody broadly inhibits multiple strains of pandemic norovirus

Researchers find way to reinvigorate exhausted immune cells and stop cancer

Virus employs powerful strategy to inhibit natural killer cell function

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News